Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A study of cannabidiol as treatment for severe symptoms of autism in Pediatric patients

Trial Profile

A study of cannabidiol as treatment for severe symptoms of autism in Pediatric patients

Planning
Phase of Trial: Phase II

Latest Information Update: 12 Oct 2018

At a glance

  • Drugs Cannabidiol (Primary)
  • Indications Autistic disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Oct 2018 According to an INSYS Therapeutics, Inc media release, the company anticipates the filing of IND (investigational new drug) application for the study in the fourth quarter of 2018.
    • 03 May 2018 New trial record
    • 26 Apr 2018 According to an INSYS Therapeutics media release, the company announced collaboration with the University of California (UC) San Diego School of Medicines Center for Medicinal Cannabis Research (CMCR) to conduct this study in 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top